Title: Revolutionizing Organ Transplants with 3D Bioprinting Spearheaded by innovators such as Nina Tandon, CEO of EpiBone, the field of 3D bioprinting has made significant headway in developing methods for printing living human tissues and potentially organs. This technology promises to alleviate organ transplant shortages and reduce the need for animal testing by providing a sustainable source of human tissue for medical research. The advancement of 3D bioprinting under women-led initiatives exemplifies the critical role of gender diversity in driving interdisciplinary and innovative solutions in STEM.
- Log in or register to contribute
Contribute to three or more articles across any domain to qualify for the Contributor badge. Please check back tomorrow for updates on your progress.